Iranian Journal of Pediatrics

Published by: Kowsar

Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis

Iraj Sedighi 1 , Abdollah Karimi 2 and Ali Amanati 3 , *
Authors Information
1 Department of Pediatrics, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Iranian Journal of Pediatrics: August 2016, 26 (4); e5514
  • Published Online: June 12, 2016
  • Article Type: Review Article
  • Received: January 29, 2016
  • Revised: April 26, 2016
  • Accepted: May 23, 2016
  • DOI: 10.5812/ijp.5514

To Cite: Sedighi I, Karimi A, Amanati A. Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis, Iran J Pediatr. 2016 ; 26(4):e5514. doi: 10.5812/ijp.5514.

Abstract
Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnotes
References
  • 1. Principles of epidemiology in public health practice: an introduction to applied epidemiology and biostatistics . 2006; : 18
  • 2. Pesco P, Bergero P, Fabricius G, Hozbor D. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology. Epidemics. 2014; 7: 13-21[DOI][PubMed]
  • 3. National Center for Immunization and Respiratory Diseases Pertussis (whooping cough), Fast Facts Centers for Disease Control and Prevention. 2015;
  • 4. Nikbin VS, Shahcheraghi F, Lotfi MN, Zahraei SM, Parzadeh M. Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran. Iran J Microbiol. 2013; 5(3): 209-14[PubMed]
  • 5. Pertussis epidemic--Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012; 61(28): 517-22[PubMed]
  • 6. Cherry JD. Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease. N Engl J Med. 2012; 367(9): 785-7[DOI][PubMed]
  • 7. Fathima S, Ferrato C, Lee BE, Simmonds K, Yan L, Mukhi SN, et al. Bordetella pertussis in sporadic and outbreak settings in Alberta, Canada, July 2004-December 2012. BMC Infect Dis. 2014; 14: 48[DOI][PubMed]
  • 8. Matthias J, Dusek C, Pritchard SP, Rutledge L, Kinchen P, Lander M, et al. Notes from the field: Outbreak of pertussis in a school and religious community averse to health care and vaccinations--columbia County, Florida, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63(30): 655[PubMed]
  • 9. Miranda C, Wozniak A, Castillo C, Geoffroy E, Zumaran C, Porte L, et al. [Presence of Bordetella holmesii in an outbreak of pertussis in Chile]. Rev Chilena Infectol. 2013; 30(3): 237-43[DOI][PubMed]
  • 10. Rodgers L, Martin SW, Cohn A, Budd J, Marcon M, Terranella A, et al. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. Clin Infect Dis. 2013; 56(3): 322-31[DOI][PubMed]
  • 11. Sizaire V, Garrido-Estepa M, Masa-Calles J. Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain. Euro Surveill. 2014; 19(32)
  • 12. Theofiles AG, Cunningham SA, Chia N, Jeraldo PR, Quest DJ, Mandrekar JN, et al. Pertussis outbreak, southeastern Minnesota, 2012. Mayo Clin Proc. 2014; 89(10): 1378-88[DOI][PubMed]
  • 13. Wu Y, Zhu B, Gao Y, Shi Z, Wang J, Wang H, et al. Clustered cases of Bordetella pertussis infection cause high levels of IgG antibodies against pertussis toxin in adolescents in Gaobeidian city, China. Epidemiol Infect. 2014; 142(4): 738-43[DOI][PubMed]
  • 14. Yarmohammadi H, Bahmani Kazeruni MH, Soofi A, Zargaran A. The First Report of Epidemic Pertussis by Bahaodowle Razi From the 15th Century Anno Domini. Iran Red Crescent Med J. 2015; 17(7): 13454[DOI][PubMed]
  • 15. Gentile A, Bhutta Z, Bravo L, Samy AG, Garcia RD, Hoosen A, et al. Pediatric disease burden and vaccination recommendations: understanding local differences. Int J Infect Dis. 2010; 14(8): 649-58[DOI][PubMed]
  • 16. Lavine JS, King AA, Andreasen V, Bjornstad ON. Immune boosting explains regime-shifts in prevaccine-era pertussis dynamics. PLoS One. 2013; 8(8): 72086[DOI][PubMed]
  • 17. Revised guidance on the choice of pertussis vaccines: July 2014. Wkly Epidemiol Rec. 2014; 25: 337-40
  • 18. World Health Organization WHO SAGE pertussis working group Background paper. SAGE April. 2014;
  • 19. Decker MD, Hosbach P, Johnson DR, Pool V, Greenberg DP. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine. J Infect Dis. 2015; 211(3): 497-8[DOI][PubMed]
  • 20. World Health Organization Immunization, Vaccines and Biologicals; Immunization surveillance, assessment and monitoring; Country Summaries of WHO/UNICEF estimated coverage. 2014;
  • 21. World Health Organization WHO vaccine-preventable diseases: monitoring system 2015 global summary. 2015;
  • 22. Ghanaie RM, Karimi A, Sadeghi H, Esteghamati A, Fallah F, Armin SH, et al. Frequency of pertussis in iranian school-age children. J Pediatric Infect Dis. 2013; 8(1): 1-5
  • 23. Shahcheraghi F, Lotfi MN, Parzadeh M. Isolation of Bordetella pertussis and bordetella parapertussis from clinical specimens at different provinces of Iran in 2009-2010. J Mazandaran Univ Med Sci. 2012; 22(88): 1-8
  • 24. Shamshiri AR, Fahimzad A, Tabatabaie SA, Shiva F, Kadivar M, Khatami A, et al. Frequency of pediatric acute respiratory tract infections in Iran; A Systematic Review. Arch Pediatr Infect Dis. 2013; 1(2): 44-52
  • 25. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis. 2010; 14(12): 1072-5[DOI][PubMed]
  • 26. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013; 131(6): 1716-22[DOI][PubMed]
  • 27. Koepke R, Eickhoff JC, Ayele RA, Petit AB, Schauer SL, Hopfensperger DJ, et al. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis. 2014; 210(6): 942-53[DOI][PubMed]
  • 28. Acosta AM, DeBolt C, Tasslimi A, Lewis M, Stewart LK, Misegades LK, et al. Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic. Pediatrics. 2015; 135(6): 981-9[DOI][PubMed]
  • 29. Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis. 2013; 56(10): 1458-65[DOI][PubMed]
  • 30. Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens. Vaccine. 2013; 31(36): 3732-8[DOI][PubMed]
  • 31. McCarthy M. Acellular vaccines provided less protection during California pertussis outbreak. BMJ. 2013; 346: 3325[DOI][PubMed]
  • 32. Warfel JM, Edwards KM. Pertussis vaccines and the challenge of inducing durable immunity. Curr Opin Immunol. 2015; 35: 48-54[DOI][PubMed]
  • 33. Matthias J, Pritchard PS, Martin SW, Dusek C, Cathey E, D'Alessio R, et al. Sustained Transmission of Pertussis in Vaccinated, 1-5-Year-Old Children in a Preschool, Florida, USA. Emerg Infect Dis. 2016; 22(2): 242-6[DOI][PubMed]
  • 34. Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect. 2014; 142(4): 685-94[DOI][PubMed]
  • 35. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010; 10(1): 36-49[DOI][PubMed]
  • 36. Advani A, Gustafsson L, Ahren C, Mooi FR, Hallander HO. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine. 2011; 29(18): 3438-42[DOI][PubMed]
  • 37. Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L. Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. Emerg Infect Dis. 2012; 18(5): 767-74[DOI][PubMed]
  • 38. Hegerle N, Guiso N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines. 2014; 13(9): 1135-46[DOI][PubMed]
  • 39. He Q, Makinen J, Berbers G, Mooi FR, Viljanen MK, Arvilommi H, et al. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis. 2003; 187(8): 1200-5[DOI][PubMed]
  • 40. Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol. 2014; 21(2): 119-25[DOI][PubMed]
  • 41. Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med. 2013; 368(6): 583-4[DOI][PubMed]
  • 42. Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis. 2014; 20(4): 626-33[DOI][PubMed]
  • 43. Bamberger E, Abu Raya B, Cohen L, Golan-Shany O, Davidson S, Geffen Y, et al. Pertussis Resurgence Associated with Pertactin-Deficient and Genetically Divergent Bordetella Pertussis Isolates in Israel. Pediatr Infect Dis J. 2015; 34(8): 898-900[DOI][PubMed]
  • 44. Zeddeman A, van Gent M, Heuvelman CJ, van der Heide HG, Bart MJ, Advani A, et al. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill. 2014; 19(33)[PubMed]
  • 45. Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis. 2015; 60(2): 223-7[DOI][PubMed]
  • 46. Bouchez V, Guiso N. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. Pathog Dis. 2015; 73(7)[DOI][PubMed]
  • 47. Caro V, Bouchez V, Guiso N. Is the Sequenced Bordetella pertussis strain Tohama I representative of the species? J Clin Microbiol. 2008; 46(6): 2125-8[DOI][PubMed]
  • 48. Haghighi F, Shahcheraghi F, Abbasi E, Eshraghi SS, Zeraati H, Mousavi SA, et al. Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients. Avicenna J Med Biotechnol. 2014; 6(3): 178-84[PubMed]
  • 49. Novotny P. Pathogenesis in Bordetella species. J Infect Dis. 1990; 161(3): 581-3[PubMed]
  • 50. Johnson K. Recent Pertussis Uptick May Come From a Different Species. Medscape Medical News from the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) 2015. 2015;
  • 51. Long GH, Karanikas AT, Harvill ET, Read AF, Hudson PJ. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci. 2010; 277(1690): 2017-25[DOI][PubMed]
  • 52. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A. 2014; 111(2): 787-92[DOI][PubMed]
  • 53. Dashti AS, Karimi A, Arjmand R, Moghadami M, Kheirkhah T, Shiva F, et al. Serologic evidence of pertussis infection in vaccinated Iranian children. Iran J Med Sci. 2012; 37(4): 260-5[PubMed]
  • 54. Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev. 2014; (9): 1478[DOI][PubMed]
  • 55. Sedighi I, Sadrosadat T. Acellular Pertussis Vaccine: Iran's Next Step to Control the Disease? Arch Pediatr Infect Dis. 2015; 3(2): 23918
  • 56. Sedighi I, Sadrosadat T. Comment on: Seroprevalence of Bordetella pertussis antibody in pregnant women in Iran. J Res Health Sci. 2014; 14(3): 236-7[PubMed]
  • 57. Sedighi I, Rahimi H, Emadoleslami MS, Fahimzad A, Hosseini F, Afsharian M, et al. Seroepidemiology of bordetella pertussis infection in fresh college students in Iran: a multicenter study. Arch Pediatr Infect Dis. 2014; 9(1)
  • 58. Ghanaie MR, Karimi A, Moradi M, Yaghobi M, Zahraee M, Mahmodi S. Acellular pertussis vaccine cost-effectiveness analysis in Iran. Vaccination in Special Satuation. 2014; : 64
  • 59. Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine. 2013; 31(4): 618-25[DOI][PubMed]
  • 60. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012; 54(1): 78-84[DOI][PubMed]
  • 61. Hashemi SH, Zamani M, Mamani M, Javedanpoor R, Rahighi AH, Nadi E. Seroprevalence of Bordetella pertussis antibody in pregnant women in Iran. J Res Health Sci. 2014; 14(2): 128-31[PubMed]
  • 62. Hashemi SH, Ranjbar M, Hajilooi M, Seif-Rabiei MA, Bolandi M, Moghimi J. Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study. BMC Infect Dis. 2009; 9: 58[DOI][PubMed]
  • 63. Eslamifar A, Ramezani A, Banifazl M, Khadem-Sadegh A, Aghakhani A. Seroprevalence of IgG Antibodies against Bordetella pertussis in Different Age Groups in Tehran, Iran. Iran J Pathol. 2012; 7(3): 171-6
  • 64. Hajia M, Rahbar M, Fallah F, Safadel N. Detection of Bordetella pertussis in Infants Suspected to have Whooping Cough. Open Respir Med J. 2012; 6: 34-6[DOI][PubMed]
  • 65. Sedaghat M, Nakhost Lotfi M, Talebi M, Saifi M, Pourshafie MR. Status of pertussis in iran. Jundishapur J Microbiol. 2014; 7(11): 12421[DOI][PubMed]
  • 66. Shojaei J, Saffar M, Hashemi A, Ghorbani G, Rezai M, Shahmohammadi S. Clinical and laboratory features of pertussis in hospitalized infants with confirmed versus probable pertussis cases. Ann Med Health Sci Res. 2014; 4(6): 910-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments